Spero Therapeutics Inc.

NASDAQ: SPRO · Real-Time Price · USD
1.93
-0.05 (-2.53%)
At close: Aug 15, 2025, 3:59 PM
2.00
3.88%
After-hours: Aug 15, 2025, 07:31 PM EDT

Spero Therapeutics Revenue

Spero Therapeutics reported an annual revenue of $27.4M, reflecting a -71.68% growth. For the quarter ending June 30, 2025, Spero Therapeutics generated $11.8M in revenue.
Revenue (ttm)
27.4M
Revenue Growth
-71.68%
Price / Sales Ratio
2.03
Revenue / Employee
856.13K
Employees
32
Market Cap
108.33M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.